Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marek Los

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 17, 2007
Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapySubbareddy Maddika, Sudharsana Rao Ande, Soumya Panigrahi, et al.
Biochimica Et Biophysica Acta|March 27, 2009
Role of BNIP3 in TNF-induced cell death--TNF upregulates BNIP3 expressionSaeid Ghavami, Mehdi Eshraghi, Kamran Kadkhoda, et al.
Biochimica Et Biophysica Acta|December 7, 2007
S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2Saeid Ghavami, Claus Kerkhoff, Walter J Chazin, et al.
Cell Research|November 26, 2009
S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3Saeid Ghavami, Mehdi Eshragi, Sudharsana R Ande, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 31, 2009
Prolonged survival and expression of neural markers by bone marrow-derived stem cells transplanted into brain lesionsEsteban Alberti, Marek Los, Rocío García, et al.
Journal of Cellular and Molecular Medicine|May 23, 2008
Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathwaySaeid Ghavami, Ahmad Asoodeh, Thomas Klonisch, et al.
Archivum Immunologiae Et Therapiae Experimentalis|May 2, 2006
Monoclonal and bispecific antibodies as novel therapeuticsEvan P Booy, Dina Johar, Srilekha Maddika, et al.
Current Medicinal Chemistry|December 16, 2006
Targeting the EGFR pathway for cancer therapyJames B Johnston, Sri Navaratnam, Marshall W Pitz, et al.
Plos One|February 10, 2011
Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for p53Saeid Ghavami, Mark M Mutawe, Pawan Sharma, et al.
Archivum Immunologiae Et Therapiae Experimentalis|May 31, 2008
Cancer stem cells as targets for cancer therapy: selected cancers as examplesSabine Hombach-Klonisch, Ted Paranjothy, Emilia Wiechec, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 17, 2007
Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapySubbareddy Maddika, Sudharsana Rao Ande, Soumya Panigrahi, et al.
Biochimica Et Biophysica Acta|March 27, 2009
Role of BNIP3 in TNF-induced cell death--TNF upregulates BNIP3 expressionSaeid Ghavami, Mehdi Eshraghi, Kamran Kadkhoda, et al.
Biochimica Et Biophysica Acta|December 7, 2007
S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2Saeid Ghavami, Claus Kerkhoff, Walter J Chazin, et al.
Cell Research|November 26, 2009
S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3Saeid Ghavami, Mehdi Eshragi, Sudharsana R Ande, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 31, 2009
Prolonged survival and expression of neural markers by bone marrow-derived stem cells transplanted into brain lesionsEsteban Alberti, Marek Los, Rocío García, et al.
Journal of Cellular and Molecular Medicine|May 23, 2008
Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathwaySaeid Ghavami, Ahmad Asoodeh, Thomas Klonisch, et al.
Archivum Immunologiae Et Therapiae Experimentalis|May 2, 2006
Monoclonal and bispecific antibodies as novel therapeuticsEvan P Booy, Dina Johar, Srilekha Maddika, et al.
Current Medicinal Chemistry|December 16, 2006
Targeting the EGFR pathway for cancer therapyJames B Johnston, Sri Navaratnam, Marshall W Pitz, et al.
Plos One|February 10, 2011
Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for p53Saeid Ghavami, Mark M Mutawe, Pawan Sharma, et al.
Archivum Immunologiae Et Therapiae Experimentalis|May 31, 2008
Cancer stem cells as targets for cancer therapy: selected cancers as examplesSabine Hombach-Klonisch, Ted Paranjothy, Emilia Wiechec, et al.
Pageof 6